|
Fibronectin Polymerization: Effects on Cell Signaling
|
5R01CA069612-11
|
$271,548
|
$135,774
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
Processing Ac-227 sources for lead-212 and radium-223 required by cancer research
|
1R41CA124302-01A1
|
$111,300
|
$22,260
|
Soderquist, Chuck
|
ALPHAMED, INC
|
|
Multiplex Detection of Mutations in Myeloproliferative Disorder and Leukemia Pati
|
1R43CA130501-01
|
$256,027
|
$256,027
|
YE, FEI
|
AMBION DIAGNOSTICS, INC.
|
|
Bead-array for rapid risk-stratification in leukemia
|
5R44CA115129-04
|
$465,644
|
$465,644
|
YE, FEI
|
AMBION DIAGNOSTICS, INC.
|
|
RTOG Tissue Bank
|
5U24CA114734-03
|
$793,043
|
$793,043
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Orthotopic models of tumor angiogenesis and blood flow
|
5R44CA099258-03
|
$374,848
|
$374,848
|
YANG, MENG
|
ANTICANCER, INC.
|
|
Dual-color tumor-host imaging models
|
5R44CA103563-03
|
$375,784
|
$375,784
|
YANG, MENG
|
ANTICANCER, INC.
|
|
ApoVax-SVN as a Novel Vaccine for Cancer Immunotherapy
|
1R41CA121665-01A2
|
$328,300
|
$328,300
|
Shirwan, Haval
|
APOIMMUNE, INC
|
|
Effect of VDJ Recombination on Scid B Cell Development
|
3R01CA073857-09S1
|
$1,334
|
$1,334
|
CHANG, YUNG
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effect of VDJ Recombination on Scid B Cell Development
|
3R01CA073857-09S2
|
$45,598
|
$45,598
|
CHANG, YUNG
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effect of VDJ Recombination on Scid B Cell Development
|
5R01CA073857-09
|
$222,001
|
$222,001
|
CHANG, YUNG
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Targeted Gene Therapy for Lymphoma
|
5R01CA113454-02
|
$254,310
|
$254,310
|
SMITH, BRUCE
|
AUBURN UNIVERSITY AT AUBURN
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
$38,400
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
SV40 Pathogenesis of Human Infections
|
5R01CA104818-04
|
$464,495
|
$464,495
|
BUTEL, JANET
|
BAYLOR COLLEGE OF MEDICINE
|
|
NR4A Nuclear Receptor Function in Leukemia
|
5R01CA111411-02
|
$258,529
|
$258,529
|
CONNEELY, ORLA
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
1P50CA126752-01
|
$2,266,618
|
$2,266,618
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genetic analysis of mouse chromosome 11
|
5R01CA115503-02
|
$457,430
|
$457,430
|
Justice, Monica
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of PML nuclear body proteins for establishment of EBV latent infection
|
5R01CA124309-02
|
$258,530
|
$258,530
|
Ling, Paul
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanisms of Cellular Transformation by HTLV-1 TAX
|
5R01CA077371-09
|
$268,279
|
$268,279
|
Marriott, Susan
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
$135,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
$10,053
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mitotic Regulation of Apoptosis in Leukemia
|
5R01CA109478-02
|
$201,652
|
$201,652
|
PATI, DEBANANDA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Regulation of Cell Growth by RNA Binding Proteins
|
5R01CA100070-05
|
$254,009
|
$254,009
|
TIMCHENKO, NIKOLAI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel Strategies for Immunotherapy fo Cancer
|
5R01CA101795-04
|
$263,284
|
$223,791
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
5P01CA084512-06
|
$978,697
|
$978,697
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Subpopulations of Human Dendritic Cells
|
5R01CA078846-09
|
$292,811
|
$292,811
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Regulation of p21waf1/cip1 by Rho and Ras signaling
|
5R01CA030721-05
|
$182,278
|
$18,228
|
OLSON, MICHAEL
|
BEATSON INSTITUTE FOR CANCER RESEARCH
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$800
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$3,910
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Training Patients and Partners for HSCT: A Novel Coping Skills Intervention
|
1R03CA130725-01
|
$84,500
|
$84,500
|
Lawsin, Catalina
|
BERNARD M. BARUCH COLLEGE
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-02
|
$333,543
|
$333,543
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Blood Flow MRI for Monitoring of Renal Cell Carcinoma
|
5R21CA121570-02
|
$292,999
|
$292,999
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-09
|
$128,678
|
$10,294
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Angiogenesis in Breast Cancer
|
5R01CA106263-03
|
$318,352
|
$143,258
|
BENJAMIN, LAURA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Oncogene-Induced Evasion from Apoptosis
|
5R01CA105306-03
|
$318,352
|
$318,352
|
KHOSRAVI-FAR, ROYA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Gab2 and Shp2 in Hematopoietic Signalling
|
5R01CA114945-10
|
$394,394
|
$394,394
|
NEEL, BENJAMIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Signal Transduction by Non-transmembrane PTPs
|
5R37CA049152-19
|
$502,926
|
$251,463
|
NEEL, BENJAMIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
ANTAGONISM OF VEGA-DRIVEN ANGIOGENESIS
|
5R01CA077357-09
|
$303,039
|
$303,039
|
SENGER, DONALD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Generation of Antiangiogenic Activity for Cancer Treat.
|
5R01CA098948-05
|
$270,081
|
$270,081
|
SUKHATME, VIKAS
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Distinct acute myeloid leukemia subclasses with CEBPA mutations
|
1R01CA118316-01A1
|
$403,102
|
$403,102
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
INTERACTING FACTORS IN HEMATOPOIESIS AND LEUKEMIA
|
5P01CA072009-10
|
$1,583,949
|
$1,583,949
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
MOLECULAR BIOLOGY OF MYELOID DIFFERENTIATION
|
5R01CA041456-22
|
$441,601
|
$441,601
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Oldenlandia diffusa for prostate cancer treatment
|
1R21CA133865-01A2
|
$170,000
|
$85,000
|
ZHOU, JIN-RONG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
High resolution analysis of linear genomic DNA in Parallel nanochannel arrays
|
5R43CA120611-02
|
$132,000
|
$66,000
|
cao, han
|
BIONANOMATRIX, LLC
|
|
Long Acting VEGF BInding Proteins for Treating Cancer
|
5R44CA099217-03
|
$335,148
|
$335,148
|
Cox, George
|
BOLDER BIOTECHNOLOGY, INC.
|
|
Cyclic AMP-mediated apoptosis in lymphoid malignancies
|
5R01CA106705-03
|
$241,199
|
$241,199
|
LERNER, ADAM
|
BOSTON MEDICAL CENTER
|
|
Multistep Lymphomagenesis/Tumorigenesis in Transgenic Mice: Protein Kinase Ck2
|
5R01CA071796-10
|
$275,767
|
$275,767
|
SELDIN, DAVID
|
BOSTON MEDICAL CENTER
|
|
Regulation of apoptosis by PI 3-kinase/Akt signaling
|
5R01CA018689-31
|
$457,492
|
$22,875
|
COOPER, GEOFFREY
|
BOSTON UNIVERSITY
|
|
Transformation of Cells by the REL Oncogene
|
5R01CA047763-20
|
$275,637
|
$275,637
|
GILMORE, THOMAS
|
BOSTON UNIVERSITY
|
|
Proteomic biomarkers for lymphoma
|
1R03CA128006-01
|
$81,250
|
$81,250
|
DENIS, GERALD
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
Total relevant funding to Hematology for this search: $466,459,388
|